Littlejohns Peter
St Georges University of London, Cranmer Terrace, London, SW17 0RE, UK.
Expert Rev Pharmacoecon Outcomes Res. 2009 Apr;9(2):151-6. doi: 10.1586/erp.09.13.
NICE has existed for 10 years. During this period, its methodological approach to developing guidance and assessing the value (cost-effectiveness) of healthcare interventions has received considerable national and international interest. At the same time, individual decisions have generated enormous controversy. This 10th anniversary provides an opportunity to look back at how the institute has responded and adapted to the various challenges and controversies. Following Lord Darzi's review of the National Health Service (UK) in 2008, the institute took on further responsibilities for setting clinical standards for the National Health Service. This article explores these developments and speculates on future trends.
英国国家卫生与临床优化研究所（NICE）已成立10年。在此期间，其制定指南以及评估医疗保健干预措施价值（成本效益）的方法在国内和国际上都引起了广泛关注。与此同时，个别决策引发了巨大争议。本次十周年纪念提供了一个契机，来回顾该机构是如何应对和适应各种挑战及争议的。继2008年达兹勋爵对英国国家医疗服务体系进行审查之后，该机构承担了为英国国家医疗服务体系制定临床标准的更多职责。本文探讨了这些发展情况，并对未来趋势进行了推测。
